| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥39.36B | ¥51.37B | -23.4% |
| Cost of Sales | ¥17.78B | ¥17.27B | +2.9% |
| Gross Profit | ¥21.58B | ¥34.10B | -36.7% |
| SG&A Expenses | ¥21.38B | ¥14.52B | +47.2% |
| Operating Income | ¥203M | ¥19.58B | -99.0% |
| Non-operating Income | ¥471M | ¥341M | +38.1% |
| Non-operating Expenses | ¥67M | ¥97M | -30.9% |
| Ordinary Income | ¥607M | ¥19.82B | -96.9% |
| Profit Before Tax | ¥1.40B | ¥19.23B | -92.7% |
| Income Tax Expense | ¥404M | ¥4.95B | -91.8% |
| Net Income | ¥992M | ¥14.29B | -93.1% |
| Net Income Attributable to Owners | ¥992M | ¥14.29B | -93.1% |
| Total Comprehensive Income | ¥379M | ¥13.47B | -97.2% |
| Depreciation & Amortization | ¥1.27B | ¥1.26B | +0.6% |
| Interest Expense | ¥21M | ¥12M | +75.0% |
| Earnings per Unit (EPU) | ¥26.16 | ¥377.23 | -93.1% |
| Distribution per Unit (DPU) | ¥115.00 | ¥115.00 | +0.0% |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥98.76B | ¥111.38B | ¥-12.62B |
| Cash and Deposits | ¥45.12B | ¥54.09B | ¥-8.98B |
| Accounts Receivable | ¥21.76B | ¥21.18B | +¥584M |
| Inventories | ¥7.83B | ¥8.80B | ¥-979M |
| Non-current Assets | ¥78.52B | ¥79.05B | ¥-524M |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥-8.06B | ¥23.93B | ¥-32.00B |
| Investing Cash Flow | ¥429M | ¥-2.43B | +¥2.86B |
| Financing Cash Flow | ¥-5.22B | ¥-2.84B | ¥-2.39B |
| Free Cash Flow | ¥-7.63B | - | - |
| Item | Value |
|---|---|
| Net Profit Margin | 2.5% |
| Gross Profit Margin | 54.8% |
| Current Ratio | 440.3% |
| Quick Ratio | 405.4% |
| Debt-to-Equity Ratio | 0.20x |
| Interest Coverage Ratio | 9.67x |
| EBITDA Margin | 3.8% |
| Effective Tax Rate | 28.9% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | -23.4% |
| Operating Income YoY Change | -99.0% |
| Ordinary Income YoY Change | -96.9% |
| Net Income Attributable to Owners YoY Change | -93.0% |
| Total Comprehensive Income YoY Change | -97.2% |
| Item | Value |
|---|---|
| Units Outstanding (incl. Treasury) | 44.14M shares |
| Treasury Units | 6.27M shares |
| Average Units Outstanding | 37.95M shares |
| NAV per Unit | ¥3,903.03 |
| EBITDA | ¥1.48B |
| Item | Amount |
|---|---|
| Q2 Distribution | ¥115.00 |
| Year-End Distribution | ¥75.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| Medicine | ¥38.08B | ¥-479M |
| RealEstate | ¥1.27B | ¥682M |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥86.30B |
| Operating Income Forecast | ¥2.10B |
| Ordinary Income Forecast | ¥2.80B |
| Net Income Attributable to Owners Forecast | ¥2.30B |
| Earnings per Unit Forecast (EPU) | ¥60.74 |
| Distribution per Unit Forecast (DPU) | ¥95.00 |
| Property, Plant & Equipment | ¥28.59B | ¥27.63B | +¥960M |
| Intangible Assets | ¥18.78B | ¥19.29B | ¥-509M |
| Goodwill | ¥13.42B | ¥14.04B | ¥-615M |
| Investment Securities | ¥17.92B | ¥18.88B | ¥-954M |
| Total Assets | ¥177.28B | ¥190.42B | ¥-13.14B |
| Current Liabilities | ¥22.43B | ¥30.35B | ¥-7.92B |
| Accounts Payable | ¥5.82B | ¥8.19B | ¥-2.36B |
| Short-term Loans | ¥3.85B | ¥3.85B | ¥0 |
| Non-current Liabilities | ¥7.04B | ¥7.43B | ¥-388M |
| Total Liabilities | ¥29.48B | ¥37.79B | ¥-8.31B |
| Total Equity | ¥147.80B | ¥152.63B | ¥-4.83B |
| Capital Stock | ¥23.85B | ¥23.85B | ¥0 |
| Capital Surplus | ¥11.41B | ¥12.93B | ¥-1.53B |
| Retained Earnings | ¥128.09B | ¥135.24B | ¥-7.15B |
| Treasury Stock | ¥-23.77B | ¥-28.23B | +¥4.46B |
| Owners' Equity | ¥147.80B | ¥152.63B | ¥-4.83B |
| Working Capital | ¥76.33B | - | - |